Upexi director granted 100,000 restricted shares

Dugan Lawrence reported acquisition or exercise transactions in this Form 4 filing.

Accepted by SEC EDGAR 07/20/2026 - 05:28 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Dugan Lawrence reported acquisition or exercise transactions in this Form 4 filing.

Upexi, Inc. director Dugan Lawrence received a grant of 100,000 shares of restricted common stock as equity compensation. The award was issued under the company’s 2019 Incentive Stock Plan and vests in four equal quarterly installments, with full vesting on July 1, 2027, subject to continued service. Following this grant, Lawrence directly holds 216,389 Upexi common shares.

Insider Trade Summary

Grant/Award: 100,000 shares

Grant/Award 1 txn

Insider Dugan Lawrence

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	100,000	$0.00	$0.00

Holdings After Transaction: Common Stock — 216,389 shares (Direct)

Holdings Before and After: Common Stock, 116,389 to 216,389 shares (Direct)

Footnotes (1)

1. F1. Represents restricted stock granted pursuant to the Issuer's 2019 Incentive Stock Plan, as amended, that vests in four equal quarterly installments, with full vesting on July 1, 2027, subject to continued service.

Key Figures

Restricted stock granted: 100,000 shares Shares owned after grant: 216,389 shares Vesting installments: 4 quarterly installments +1 more

4 metrics

Restricted stock granted 100,000 shares Equity award of common stock to director Dugan Lawrence

Shares owned after grant 216,389 shares Total direct Upexi common shares held by Lawrence following the award

Vesting installments 4 quarterly installments Restricted stock vests in four equal quarterly tranches

Full vesting date July 1, 2027 Date when all granted restricted shares are scheduled to be fully vested

Key Terms

restricted stock, 2019 Incentive Stock Plan, vests in four equal quarterly installments

3 terms

restricted stock financial

"Represents restricted stock granted pursuant to the Issuer's 2019 Incentive"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

2019 Incentive Stock Plan financial

"granted pursuant to the Issuer's 2019 Incentive Stock Plan, as amended"

vests in four equal quarterly installments financial

"that vests in four equal quarterly installments, with full vesting"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Upexi (UPXI) director Dugan Lawrence report?

Director Dugan Lawrence reported receiving a grant of 100,000 shares of restricted common stock from Upexi. The award is equity compensation, not an open-market purchase, and was issued under the company’s 2019 Incentive Stock Plan with multi-year vesting conditions.

How many Upexi (UPXI) shares were granted to Dugan Lawrence in this Form 4?

The filing shows a grant of 100,000 restricted shares of Upexi common stock to director Dugan Lawrence. These shares were awarded at a stated price of $0.00 per share as compensation rather than a cash purchase on the open market.

What is the vesting schedule for Dugan Lawrence’s Upexi (UPXI) restricted stock?

The 100,000 restricted shares vest in four equal quarterly installments, with full vesting scheduled for July 1, 2027, subject to continued service. This means portions of the award become exercisable over time rather than immediately.

What are Dugan Lawrence’s Upexi (UPXI) share holdings after this grant?

After the reported grant, Dugan Lawrence directly owns 216,389 shares of Upexi common stock. This figure reflects his total direct holdings following the 100,000-share restricted stock award disclosed in the Form 4 filing.

Was the Upexi (UPXI) restricted stock grant made under a company incentive plan?

Yes. The filing states the award represents restricted stock granted under Upexi’s 2019 Incentive Stock Plan, as amended. The plan-based grant vests in four equal quarterly installments, fully vesting on July 1, 2027, assuming continued service.

Is the Upexi (UPXI) Form 4 transaction tied to a Rule 10b5-1 trading plan?

No. The Form 4’s Rule 10b5-1 checkbox is not marked as an affirmative trading plan. The reported activity is a compensatory restricted stock grant rather than discretionary buying or selling pursuant to a pre-arranged Rule 10b5-1 plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dugan Lawrence

(Last) (First) (Middle)

3030 N ROCKY POINT DRIVE

STE. 420

(Street)

TAMPA FLORIDA 33607

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
UPEXI, INC. [ UPXI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/03/2026		A		100,000(1)	A	$0	216,389	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock granted pursuant to the Issuer's 2019 Incentive Stock Plan, as amended, that vests in four equal quarterly installments, with full vesting on July 1, 2027, subject to continued service.

	/s/ Lawrence Dugan	07/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)